SkinnyRx vs Zealthy
SkinnyRx has an open FDA warning letter dated February 20, 2026. Zealthy has an open FDA warning letter dated September 9, 2025. No price lines up like for like. They share compounded semaglutide injection, but SkinnyRx's $99 is a first-month price, while Zealthy's $286 covers the medication only, with a separate membership on top.
To see where both sit among the other sellers, read our best weight-loss injection providers board.
The record
SkinnyRx / Zealthy
Featured pick (affiliate partner)
SkinnyRx
6.3/10
Zealthy
5.6/10
SkinnyRx is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Zealthy pays us nothing. The scores are computed the same way for both and are shown as computed (SkinnyRx 6.3, Zealthy 5.6). How we are paid
What the record shows
- 01
SkinnyRx has an open FDA warning letter dated February 20, 2026. Zealthy has an open FDA warning letter dated September 9, 2025.
- 02
Neither names the pharmacy that compounds its medication.
- 03
No price lines up like for like. They share compounded semaglutide injection, but SkinnyRx's $99 is a first-month price, while Zealthy's $286 covers the medication only, with a separate membership on top.
- 04
Only SkinnyRx lists a price for brand-name semaglutide pen, brand-name tirzepatide pen and compounded oral semaglutide.
- 05
Zealthy covers three states SkinnyRx does not.
Prices and terms, product by product
A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.
SkinnyRx
Zealthy
$99/mo
first month only; not compared
$286/mo
medication only, membership extra; not compared
$99/mo
first month only; not compared
$351/mo
medication only, membership extra; not compared
$1,400/mo
$16,800 a year
$1,400/mo
$16,800 a year
$149/mo
first month only; not compared
$199/mo
first month only; not compared
$248/mo
$2,976 a year
$248/mo
$2,976 a year
Read off each seller’s own pages. SkinnyRx: October 30, 2026. Zealthy: October 17, 2026. Every plan and dose we hold is on the full review.
The case for each
The case for SkinnyRx
6.3/10- Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Zealthy does not price
- Open FDA warning letter, February 20, 2026
- Names no compounding pharmacy
The case for Zealthy
5.6/10The record gives Zealthy no edge on this pair.
- Open FDA warning letter, September 9, 2025
- Names no compounding pharmacy
- Lowest price covers the medication only, with a separate membership on top
Scores
SkinnyRx 6.3 · Zealthy 5.6 out of 10. Six weighted parts.
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
The score is the same formula for every seller. Payment does not enter it. Method
SkinnyRx vs Zealthy: questions
Other sellers we are paid by
Affiliate partners outside this pair. Each has its own record and review, scored the same way.
- MEDGm7.3
From $169/mo prepaid
Visit site - YourEra9.0
From $99/mo
Visit site - Embody9.3
From $79/mo
Visit site
Sellers closest to these two
- SkinnyRx vs Found
- SkinnyRx vs ShedRx
- SkinnyRx vs Mochi Health
- SkinnyRx vs Hims
- Zealthy vs TrimRx
- Zealthy vs Remedy Meds
Matched on molecule, form and price. Every pair we list · The register
Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks